American College Of Physicians Officially Recommends GLP-1s Like Ozempic For Diabetes Treatment—Despite Shortage Concerns

Forbes April 19, 2024
Arianna Johnson

Topline

The American College of Physicians issued new guidelines for Type 2 diabetes treatment, which for the first time recommends the use of GLP-1s and another class of diabetes drugs called SGLT-2s alongside metformin, though this may exacerbate the ongoing drug shortages of several GLP-1s.

Key Facts

Will This Affect The Supply Of Glp-1s?

Some GLP-1 medications are already in a shortage due to high demand. Though all doses of diabetes drug Ozempic are available, all doses of Nordisk’s weight loss drug Wegovy are in a shortage except for its highest dose, 2.4 milligrams. Nordisk hasn’t provided a timeframe for when the supply will improve. Nordisk told Forbes it will gradually increase supply of all doses of Wegovy throughout the...

Today's Sponsors

Today's Sponsor